Alain Munoz
Chairman chez ACTICOR BIOTECH SAS
Fortune : 1 M $ au 31/03/2024
Relations actives
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Thomas Meyer | M | 56 |
Auris Medical AG
Auris Medical AG Medical SpecialtiesHealth Technology Auris Medical AG manufactures electronic devices for ear disorders. It develops novel pharmaceutical therapies to protect hearing and to silence tinnitus. The company was founded by Thomas Meyer in April 2003 and is headquartered in Basel, Switzerland. | 21 ans |
Franck Grimaud | M | 58 |
Vivalis SA
Vivalis SA Pharmaceuticals: OtherHealth Technology Vivalis SA manufactures human and animal vaccines. The firm specializes in the research and development of vaccines and antiviral molecules, as well as in recombinant therapeutic protein and monoclonal antibody expression systems development. The firm's embryonic stem cells are used for practical applications in human and animal health. It also helps its clients in a case by case basis for the development of processes in the frame of service agreement. The company was founded in April 1999 and is headquartered in France.
Intercell Austria AG
| 25 ans |
Mats Blom | M | 59 |
Auris Medical AG
Auris Medical AG Medical SpecialtiesHealth Technology Auris Medical AG manufactures electronic devices for ear disorders. It develops novel pharmaceutical therapies to protect hearing and to silence tinnitus. The company was founded by Thomas Meyer in April 2003 and is headquartered in Basel, Switzerland. | 14 ans |
Adam Sinding Steensberg | M | 50 | 14 ans | |
Rory Nealon | M | 56 | 5 ans | |
Gilles Avenard | M | - | 11 ans | |
Joe Wiley | M | 53 | 5 ans | |
Alf Gunnar Martin Nicklasson | M | 69 | 9 ans | |
Margrit Schwarz | M | 60 |
Auris Medical AG
Auris Medical AG Medical SpecialtiesHealth Technology Auris Medical AG manufactures electronic devices for ear disorders. It develops novel pharmaceutical therapies to protect hearing and to silence tinnitus. The company was founded by Thomas Meyer in April 2003 and is headquartered in Basel, Switzerland. | 3 ans |
Thomas Lingelbach | M | 60 |
Intercell Austria AG
| 11 ans |
Ray Stafford | M | 77 | 8 ans | |
Jeffrey Berkowitz | M | 58 | 5 ans | |
Bernadette Connaughton | F | 65 | 5 ans | |
Sophie Binay | M | - | - | |
Stephen Joyce | M | - | - | |
Jean-Pierre Cazenave | M | - | - | |
Philippe Billiald | M | - | - | |
Ivan M. Møller | M | 52 | 6 ans | |
Frédéric Grimaud | M | 59 |
Vivalis SA
Vivalis SA Pharmaceuticals: OtherHealth Technology Vivalis SA manufactures human and animal vaccines. The firm specializes in the research and development of vaccines and antiviral molecules, as well as in recombinant therapeutic protein and monoclonal antibody expression systems development. The firm's embryonic stem cells are used for practical applications in human and animal health. It also helps its clients in a case by case basis for the development of processes in the frame of service agreement. The company was founded in April 1999 and is headquartered in France.
Intercell Austria AG
| 12 ans |
Kirsten Drejer | M | 68 | 6 ans | |
Covadonga Pañeda | M | 51 | - | |
Leonard Kruimer | M | 66 | 5 ans | |
Patricia Zilliox | M | - | 1 ans | |
Christina Sonnenborg Bredal | F | 39 | 4 ans | |
Helen Phillips | M | - | - | |
Julie Eastwood | F | - | 5 ans | |
Stephen Wills | M | 67 | 5 ans | |
Anneline Nansen | F | 55 | 3 ans | |
Eric Cohen | M | - | - | |
Aymeric Humblot | M | - | - | |
Jessica Jami | F | - | 5 ans | |
Marcel Gremaud | M | 66 | 3 ans | |
James Stearns | M | - | - | |
Tracy Cunningham | M | - | 4 ans | |
Henriette Wennicke | F | - | 2 ans | |
Antoine Lebel | M | - | - | |
Andrea Comenducci | M | - | 6 ans | |
George Hampton | M | 54 | 5 ans | |
John McEvoy | M | 37 | 7 ans | |
Elizabeth Jobes | F | 57 | 4 ans | |
Armando Anido | M | 66 |
Auris Medical AG
Auris Medical AG Medical SpecialtiesHealth Technology Auris Medical AG manufactures electronic devices for ear disorders. It develops novel pharmaceutical therapies to protect hearing and to silence tinnitus. The company was founded by Thomas Meyer in April 2003 and is headquartered in Basel, Switzerland. | 8 ans |
David M. Kendall | M | 62 | 2 ans | |
Catherine Boule | F | - | - | |
Samuel Wickline | M | 71 | 3 ans | |
Alain Parthoens | M | 64 | 6 ans | |
Patrick Volkert Vink | M | 60 | 5 ans | |
Roni Mamluk | M | 57 | 3 ans | |
Rajkumar Kannan | M | 61 | 3 ans | |
Jean-Paul Ansel | M | 74 | 5 ans | |
Rinaldo del Bono | M | - | - | |
Guy Heynen | M | - | - | |
Donald Stern | M | 78 | 5 ans | |
Yannick Plétan | M | - | 7 ans | |
Leila Nicolas | F | - | - | |
Adeline Meilhoc | F | - | - |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Mogens Vang Rasmussen | M | - | 7 ans | |
Hernan Levett | M | 49 | 2 ans | |
Majid Mehtali | M | 63 |
Vivalis SA
Vivalis SA Pharmaceuticals: OtherHealth Technology Vivalis SA manufactures human and animal vaccines. The firm specializes in the research and development of vaccines and antiviral molecules, as well as in recombinant therapeutic protein and monoclonal antibody expression systems development. The firm's embryonic stem cells are used for practical applications in human and animal health. It also helps its clients in a case by case basis for the development of processes in the frame of service agreement. The company was founded in April 1999 and is headquartered in France. | 10 ans |
Sven Zimmermann | M | 53 |
Auris Medical Holding AG /Old/
Auris Medical Holding AG /Old/ Medical SpecialtiesHealth Technology Auris Medical Holding AG engages in the research, development, and commercialization of pharmaceutical products for inner ear disorders. Its products portfolio targets to treat tinnitus, Menière's disease, and hearing loss. The company was founded by Thomas Meyer on April 1, 1998 and is headquartered in Zug, Switzerland. | - |
John Hyttel | M | 78 | 15 ans | |
Berndt A. E. Modig | M | 65 |
Auris Medical Holding AG /Old/
Auris Medical Holding AG /Old/ Medical SpecialtiesHealth Technology Auris Medical Holding AG engages in the research, development, and commercialization of pharmaceutical products for inner ear disorders. Its products portfolio targets to treat tinnitus, Menière's disease, and hearing loss. The company was founded by Thomas Meyer on April 1, 1998 and is headquartered in Zug, Switzerland. | 4 ans |
Didier Hoch | M | 68 |
Genticel SA
Genticel SA BiotechnologyHealth Technology Genticel SA operates as a clinical stage biotechnology company, which focuses on the development of immunotherapies designed to fight infectious diseases and cancer. The company was founded by Bénédikt Timmerman and Ludovic de Meeus d'Argenteuil on October 15, 2001 and is headquartered in Labège, France. | 6 ans |
Catherine Moukheibir | F | 64 | 5 ans | |
Rosemary Crane | F | 64 | 4 ans | |
Rie Schultz Hansen | M | - | 3 ans | |
Geneviève Garrigos | M | 68 |
Novagali Pharma SA
Novagali Pharma SA Pharmaceuticals: MajorHealth Technology Novagali Pharma SA specializes in research, development and marketing of ophthalmic drugs. Their product pipeline includes products at various stages of development, which address diseases encountered at the three different segment levels of the eye which are surface, anterior and posterior segments. Some of these diseases are dry eye, allergy, glaucoma and retinopathies. Their formulations are based on their technology platforms Novasorb and Eyeject, which optimize bioavailability of drugs as well as safety and comfort for the patient. The company was founded on August 8, 2000 and is headquartered in Evry, France. | - |
Céline Breda | F | 54 |
Vivalis SA
Vivalis SA Pharmaceuticals: OtherHealth Technology Vivalis SA manufactures human and animal vaccines. The firm specializes in the research and development of vaccines and antiviral molecules, as well as in recombinant therapeutic protein and monoclonal antibody expression systems development. The firm's embryonic stem cells are used for practical applications in human and animal health. It also helps its clients in a case by case basis for the development of processes in the frame of service agreement. The company was founded in April 1999 and is headquartered in France. | 8 ans |
Lani Pollworth Morvan | M | - | 2 ans | |
Mads Vindahl Kronborg | M | - | - | |
Michael Owen | M | 73 | 12 ans | |
Emmanuel Dulac | M | 55 | 3 ans | |
Valérie Leroy | F | - |
Genticel SA
Genticel SA BiotechnologyHealth Technology Genticel SA operates as a clinical stage biotechnology company, which focuses on the development of immunotherapies designed to fight infectious diseases and cancer. The company was founded by Bénédikt Timmerman and Ludovic de Meeus d'Argenteuil on October 15, 2001 and is headquartered in Labège, France. | - |
Hanne Leth Hillman | F | 59 | 5 ans | |
Britt Meelby Jensen | F | 51 | 4 ans | |
Matthew D. Dallas | M | 49 | 3 ans | |
Raoul F. Dias | M | - | - | |
Corinne Le Goff | M | 58 | 1 ans | |
Rasmus Just | M | 48 | 14 ans | |
Gerald Heinz Möller | M | 80 |
Genticel SA
Genticel SA BiotechnologyHealth Technology Genticel SA operates as a clinical stage biotechnology company, which focuses on the development of immunotherapies designed to fight infectious diseases and cancer. The company was founded by Bénédikt Timmerman and Ludovic de Meeus d'Argenteuil on October 15, 2001 and is headquartered in Labège, France. | - |
Helle Størum | F | 57 | 9 ans | |
Florian Reinaud | M | 51 | - | |
Rémi Droller | M | 48 |
Novagali Pharma SA
Novagali Pharma SA Pharmaceuticals: MajorHealth Technology Novagali Pharma SA specializes in research, development and marketing of ophthalmic drugs. Their product pipeline includes products at various stages of development, which address diseases encountered at the three different segment levels of the eye which are surface, anterior and posterior segments. Some of these diseases are dry eye, allergy, glaucoma and retinopathies. Their formulations are based on their technology platforms Novasorb and Eyeject, which optimize bioavailability of drugs as well as safety and comfort for the patient. The company was founded on August 8, 2000 and is headquartered in Evry, France. | - |
Jørgen Lindegaard | M | 76 | - | |
Peter James Arthur Benson | M | 69 | - | |
Antoine Papiernik | M | 56 |
Auris Medical Holding AG /Old/
Auris Medical Holding AG /Old/ Medical SpecialtiesHealth Technology Auris Medical Holding AG engages in the research, development, and commercialization of pharmaceutical products for inner ear disorders. Its products portfolio targets to treat tinnitus, Menière's disease, and hearing loss. The company was founded by Thomas Meyer on April 1, 1998 and is headquartered in Zug, Switzerland. | - |
Eva Steiness | M | 83 | 19 ans | |
Philippe Rousseau | M | 53 |
Vivalis SA
Vivalis SA Pharmaceuticals: OtherHealth Technology Vivalis SA manufactures human and animal vaccines. The firm specializes in the research and development of vaccines and antiviral molecules, as well as in recombinant therapeutic protein and monoclonal antibody expression systems development. The firm's embryonic stem cells are used for practical applications in human and animal health. It also helps its clients in a case by case basis for the development of processes in the frame of service agreement. The company was founded in April 1999 and is headquartered in France. | 4 ans |
Philip Parkinson | M | 66 |
Novagali Pharma SA
Novagali Pharma SA Pharmaceuticals: MajorHealth Technology Novagali Pharma SA specializes in research, development and marketing of ophthalmic drugs. Their product pipeline includes products at various stages of development, which address diseases encountered at the three different segment levels of the eye which are surface, anterior and posterior segments. Some of these diseases are dry eye, allergy, glaucoma and retinopathies. Their formulations are based on their technology platforms Novasorb and Eyeject, which optimize bioavailability of drugs as well as safety and comfort for the patient. The company was founded on August 8, 2000 and is headquartered in Evry, France. | - |
Albert Saporta | M | 73 | 7 ans | |
Christian Thorkildsen | M | 56 | - | |
Oliver Kubli | M | 51 |
Auris Medical Holding AG /Old/
Auris Medical Holding AG /Old/ Medical SpecialtiesHealth Technology Auris Medical Holding AG engages in the research, development, and commercialization of pharmaceutical products for inner ear disorders. Its products portfolio targets to treat tinnitus, Menière's disease, and hearing loss. The company was founded by Thomas Meyer on April 1, 1998 and is headquartered in Zug, Switzerland. | 8 ans |
Calvin Roberts | M | 71 |
Auris Medical Holding AG /Old/
Auris Medical Holding AG /Old/ Medical SpecialtiesHealth Technology Auris Medical Holding AG engages in the research, development, and commercialization of pharmaceutical products for inner ear disorders. Its products portfolio targets to treat tinnitus, Menière's disease, and hearing loss. The company was founded by Thomas Meyer on April 1, 1998 and is headquartered in Zug, Switzerland. | - |
Daniël Jan Ellens | M | 76 | - | |
Philippe Peltier | M | 52 |
Genticel SA
Genticel SA BiotechnologyHealth Technology Genticel SA operates as a clinical stage biotechnology company, which focuses on the development of immunotherapies designed to fight infectious diseases and cancer. The company was founded by Bénédikt Timmerman and Ludovic de Meeus d'Argenteuil on October 15, 2001 and is headquartered in Labège, France.
Novagali Pharma SA
Novagali Pharma SA Pharmaceuticals: MajorHealth Technology Novagali Pharma SA specializes in research, development and marketing of ophthalmic drugs. Their product pipeline includes products at various stages of development, which address diseases encountered at the three different segment levels of the eye which are surface, anterior and posterior segments. Some of these diseases are dry eye, allergy, glaucoma and retinopathies. Their formulations are based on their technology platforms Novasorb and Eyeject, which optimize bioavailability of drugs as well as safety and comfort for the patient. The company was founded on August 8, 2000 and is headquartered in Evry, France. | - |
Arthur Donny Strosberg | M | - | 15 ans | |
Jutta af Rosenborg | F | 65 | - | |
Piet Serrure | M | 70 | - | |
David Solomon | M | 63 | 7 ans | |
Mary C. Tanner | F | 73 |
Genticel SA
Genticel SA BiotechnologyHealth Technology Genticel SA operates as a clinical stage biotechnology company, which focuses on the development of immunotherapies designed to fight infectious diseases and cancer. The company was founded by Bénédikt Timmerman and Ludovic de Meeus d'Argenteuil on October 15, 2001 and is headquartered in Labège, France. | - |
Philippe Nerin | M | - | 2 ans |
Statistiques
Pays | Relations | % du total |
---|---|---|
France | 38 | 38,00% |
Danemark | 35 | 35,00% |
Irlande | 15 | 15,00% |
Bermudes | 9 | 9,00% |
Suisse | 9 | 9,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Alain Munoz
- Réseau Personnel